Body mass index and risk for oral contraceptive failure: a case-cohort study in South Carolina
- PMID: 16516489
- DOI: 10.1016/j.annepidem.2006.01.001
Body mass index and risk for oral contraceptive failure: a case-cohort study in South Carolina
Abstract
Purpose: Studies have suggested that obesity is associated with an increased risk for oral contraceptive (OC) failure. We conducted a case-cohort study in South Carolina to examine the association between body mass index (BMI) and OC failure by using population-based data sources.
Methods: Our cohort sample from the source population consists of 205 women who reported using OCs to prevent pregnancy on the 1999 Behavioral Risk Factor Surveillance System survey. The 153 women who reported using OCs at the time of conception on the 2000 Pregnancy Risk Assessment Monitoring System survey represent the case sample that arose from the source population. Logistic regression was used to obtain odds ratios (ORs) and 95% confidence intervals (CIs).
Results: In unadjusted models with normal BMI (20 to 24.9 kg/m(2)) as the comparison, greater BMI was associated significantly with OC failure (overweight [25 to 29.9 kg/m(2)], OR = 2.54; 95% CI, 1.18-5.50; and obese [> or =30 kg/m(2)], OR = 2.82; 95% CI, 1.05-7.58). After adjustment for education, income, and race/ethnicity, associations were attenuated and no longer statistically significant.
Conclusions: In this heterogeneous population, we found a suggestion that overweight and obese women may be at increased risk for OC failure. However, long-term prospective studies are needed to study this association in diverse populations.
Similar articles
-
The role of body weight in oral contraceptive failure: results from the 1995 national survey of family growth.Ann Epidemiol. 2005 Aug;15(7):492-9. doi: 10.1016/j.annepidem.2004.10.009. Epub 2005 Jan 7. Ann Epidemiol. 2005. PMID: 16029841
-
Obesity and oral contraceptive failure: findings from the 2002 National Survey of Family Growth.Am J Epidemiol. 2007 Dec 1;166(11):1306-11. doi: 10.1093/aje/kwm221. Epub 2007 Sep 4. Am J Epidemiol. 2007. PMID: 17785712
-
Body mass index, weight, and oral contraceptive failure risk.Obstet Gynecol. 2005 Jan;105(1):46-52. doi: 10.1097/01.AOG.0000149155.11912.52. Obstet Gynecol. 2005. PMID: 15625141
-
Risk of stroke in women exposed to low-dose oral contraceptives: a critical evaluation of the evidence.Arch Intern Med. 2004 Apr 12;164(7):741-7. doi: 10.1001/archinte.164.7.741. Arch Intern Med. 2004. PMID: 15078643 Review.
-
Obesity and oral contraceptives: a clinician's guide.Best Pract Res Clin Endocrinol Metab. 2013 Feb;27(1):55-65. doi: 10.1016/j.beem.2012.09.001. Epub 2012 Oct 10. Best Pract Res Clin Endocrinol Metab. 2013. PMID: 23384746 Review.
Cited by
-
Contraception and the obese woman.J Am Assoc Nurse Pract. 2013 May;25(5):223-33. doi: 10.1111/1745-7599.12011. Epub 2013 Feb 27. J Am Assoc Nurse Pract. 2013. PMID: 24170564 Free PMC article. Review.
-
No association between body size and frequency of sexual intercourse among oral contraceptive users.Ann Epidemiol. 2014 Sep;24(9):655-9. doi: 10.1016/j.annepidem.2014.06.004. Epub 2014 Jun 17. Ann Epidemiol. 2014. PMID: 25034574 Free PMC article.
-
Combined hormonal contraceptive (CHC) use among obese women and contraceptive effectiveness: a systematic review.Contraception. 2017 Feb;95(2):117-129. doi: 10.1016/j.contraception.2016.10.010. Epub 2016 Nov 4. Contraception. 2017. PMID: 27823942 Free PMC article.
-
Validity of self-reported height and weight in women of reproductive age.Matern Child Health J. 2007 Mar;11(2):137-44. doi: 10.1007/s10995-006-0157-0. Epub 2006 Oct 26. Matern Child Health J. 2007. PMID: 17066316
-
Effect of obesity on the pharmacokinetics of drugs in humans.Clin Pharmacokinet. 2010;49(2):71-87. doi: 10.2165/11318100-000000000-00000. Clin Pharmacokinet. 2010. PMID: 20067334 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical